Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.

Abstract

Many psychostimulants, including cocaine and methamphetamine, interact with sigma (σ) receptors at physiologically relevant concentrations. The potential therapeutic relevance of this interaction is underscored by the ability to selectively target σ receptors to mitigate many behavioral and physiological effects of psychostimulants in animal and cell-based model systems. This chapter begins with an overview of these enigmatic proteins. Provocative preclinical data showing that σ ligands modulate an array of cocaine and methamphetamine effects are summarized, along with emerging areas of research. Together, the literature suggests targeting of σ receptors as an innovative option for combating undesired actions of psychostimulants through both neuronal and glial mechanisms.

DOI: 10.1016/B978-0-12-420118-7.00009-3

12 Figures and Tables

Cite this paper

@article{Matsumoto2014SigmaR, title={Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.}, author={Rae R. Matsumoto and Linda Nguyen and Nidhi Kaushal and Matthew J. Robson}, journal={Advances in pharmacology}, year={2014}, volume={69}, pages={323-86} }